Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

Read more

News From Corium

Corium, Inc., Announces Availability of AZSTARYS (serdexmethylphenidate and dexmethylphenidate)

Corium, Inc., announces that AZSTARYS (serdexmethylphenidate and dexmethylphenidate) is now available for prescription in the United States.

Read the press release

Full Prescribing Information


A portfolio company of img